Obesity Strongly Linked to Incident Long-Term Prescription Opioid Use
The rising incidence of obesity in the United States may be contributing to the widespread use of long-term prescription opioids for noncancer pain.
The rising incidence of obesity in the United States may be contributing to the widespread use of long-term prescription opioids for noncancer pain.
Obesity and rapid weight gain during the transition to adulthood period may be associated with an increased risk for pain interference in young adults.
The use of metoclopramide and non-steroidal anti-inflammatory drugs during migraine attacks may be associated with insulin resistance in women with migraine.
Depression and obesity may be associated with chronic hip pain.
Weight loss may result in improved pain, symptom severity, depression, and fibromyalgia scores in patients with obesity.
A large variability in the impact of physical activity on pain during acute migraine attacks was found in women who were overweight and obese.
Patients who are obese and experience knee pain were found to have improved pressure pain threshold at the patella and the wrist after weight loss associated with bariatric surgery vs medical management.
Special caution is warranted in the administration of pain treatment to patients with severe obesity, and additional research in this population is needed.
Weight loss was shown to decrease diffuse pain and symptom severity related to pain, with more reductions observed with greater weight loss.
Approximately 37% of US adults aged 60 years and older have been diagnosed with knee osteoarthritis, and the number is expected to rise.